BDBM632960 US20230348453, Compound C8

SMILES Cc1nn(C)c(C)c1NC(=O)c1cnc(Nc2cc(nc(C)n2)N2CCN(CCO)CC2)s1

InChI Key InChIKey=DBHZLVWJMDYRBG-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 632960   

TargetTyrosine-protein kinase ABL1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 2.96nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 22.8nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 22.8nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetGamma-aminobutyric acid receptor subunit alpha-1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 296nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 2.80E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK1(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 2.80E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 4.44E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 4.44E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 9.73E+3nMAssay Description:The IC50 for the inhibition of ABL1 by dasatinib, by C7 and by B3 is approximately 1.5 nM, 5.1 nM and 1.6 nM, and of SRC is 1.5 nM, 1.5 nM and 1.5 nM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetSerine/threonine-protein kinase SIK2(Human)
Iomx Therapeutics

US Patent
LigandPNGBDBM632960(US20230348453, Compound C8 | US12172993, Compound ...)
Affinity DataIC50: 9.73E+3nMAssay Description:Briefly, a radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the five protein kinases. All...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2025
Entry Details
US Patent